Olainfarm AS (OLF1R, Nasdaq Riga)

Latvia based pharmaceutical company entangled into dispute between shareholders trading for less than 5 times last year’s earnings, growing top line at around 10% annually with consistently high ROE, trading at below company’s book value. We believe that shareholder disputes will resolve in time and will not fundamentally effect Olainfarm’s business prospects.

MCap 99M

PE 4.4

PBv 0.8

PS 0.7

DY 1% (5Y average)

ROE 14% (5Y average)

CAGR is 10%

Yearly stock trading volume is less than 10% making it an overlooked stock.

Olainfarm is the leading manufacturer in the chemical and pharmaceutical sector of the Baltic States with more than 45 years of experience.

Listed on NASDAQ Riga since 1997.

Olainfarm is is engaged in the manufacturing of finished drug forms and chemical pharmaceutical products in the Baltics. The group operates its activities through Medicine Production segment, Wholesale segment, Retail segment, Compression Materials segment and other segments.

Olainfarm exports to more than 60 countries worldwide and its main export markets are Russia, Ukraine, Belarus, The Netherlands, Kazakhstan, Uzbekistan, and
Germany. Farthest export market is Australia. Net sales break down geographically as follows: Latvia (29.4%), Russia (29.9%), Belarus (10.8%), Ukraine (9%), Europe (7.6%) and others (13.3%).

Olainfarm produces cardiological, neurologic, diuretic, spasmologic and antiallergic drug preparations, medicaments treating the digestive system, antibiotics and food supplements, as well as various active chemical ingredients and raw chemical materials. Its products include Amlodipine, Clonazepam, Euphillin, Furosemide, Furagin, Midolat, Protionol and Gripoflex, among others.

Company shareholders, who own 5% or more of issuer’s capital: Estate of Maligins Valerijs 46%, Nika Saveljeva 7.8%, Signe Baldere-Sildedze 7.8%, Irina Maligina 7.8%.

Financials and other info: https://lv.olainfarm.com/en/investors/

Long Olainfarm AS as of 01/21/2020

Purchase price: 7.22 Eu

Published by

Investment Runner

Investing without borders. Absolute return. We prefer smaller. We prefer cheaper. We prefer less liquid and overlooked. Writing about stocks we are buying for a diversified deep value portfolio. These types of stocks tend to be very volatile and can go bankrupt. They are not well suited for a concentrated portfolios. NOT a deep dive extensive write-ups. Some numbers can be rough approximations and intended to be used as blunt valuation guideposts. We do not care about decimal points. This is not investment advise. Do your own research.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s